J&J taking $100M charge for Venezuela devaluation

Published



NEW BRUNSWICK, N.J. (AP) — Health care giant Johnson & Johnson said Monday that it expects to take a charge of about $100 million to its first-quarter net income due to Venezuela’s currency devaluation.

Johnson & Johnson, the world’s biggest seller of health care products, said the decision is based on its preliminary assessment of the impact of the Venezuelan government’s move, which took effect Feb. 13. The charge amounts to 4 cents per share.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.